Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127972741 | 12797274 | 1 | I | 20160823 | 20160930 | 20160930 | EXP | CA-ROCHE-1833049 | ROCHE | 73.00 | YR | M | Y | 64.40000 | KG | 20160930 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127972741 | 12797274 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90 MINUTES ON DAY 1 AND DAY 15 IN 28 DAYS CYCLE?ALSO RECEIVED ON 24/AUG/2010, 21/SEP/2010, 1 | U | 125085 | 1476 | MG | |||||||
| 127972741 | 12797274 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90 MINUTES ON DAY 1 AND DAY 15 IN 28 DAYS CYCLE?ALSO RECIEVED ON 08/FEB/2011 | U | 125085 | 644 | MG | |||||||
| 127972741 | 12797274 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90 MINUTES ON DAY 1 AND DAY 15 IN 28 DAYS CYCLE?ALSO RECEIVED ON 11/JAN/2011 | U | 125085 | 1288 | MG | |||||||
| 127972741 | 12797274 | 4 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ON DAYS 1, 8, 15 AND 22 EVERY 28 DAYS?ALSO RECEIVED ON 24/AUG/2010, 21/SEP/2010 | U | 0 | 100 | MG | |||||||
| 127972741 | 12797274 | 5 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ON DAYS 1, 8, 15 AND 22 EVERY 28 DAYS | U | 0 | 80 | MG | |||||||
| 127972741 | 12797274 | 6 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ON DAYS 1, 8, 15 AND 22 EVERY 28 DAYS | U | 0 | 35 | MG | |||||||
| 127972741 | 12797274 | 7 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ON DAYS 1, 8, 15 AND 22 EVERY 28 DAYS | U | 0 | 45 | MG | |||||||
| 127972741 | 12797274 | 8 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ON DAYS 1, 8, 15 AND 22 EVERY 28 DAYS | U | 0 | 40 | MG | |||||||
| 127972741 | 12797274 | 9 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ON DAYS 1, 8, 15 AND 22 EVERY 28 DAYS | U | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127972741 | 12797274 | 1 | Hepatocellular carcinoma |
| 127972741 | 12797274 | 4 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127972741 | 12797274 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127972741 | 12797274 | Anaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127972741 | 12797274 | 1 | 20100727 | 0 | ||
| 127972741 | 12797274 | 2 | 20101116 | 0 | ||
| 127972741 | 12797274 | 3 | 20101214 | 0 | ||
| 127972741 | 12797274 | 4 | 20100727 | 0 | ||
| 127972741 | 12797274 | 5 | 20101019 | 0 | ||
| 127972741 | 12797274 | 6 | 20101116 | 0 | ||
| 127972741 | 12797274 | 7 | 20101214 | 0 | ||
| 127972741 | 12797274 | 8 | 20110111 | 0 | ||
| 127972741 | 12797274 | 9 | 20110208 | 0 |